| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 11 |
| 1 | OLAPARIB | 11 |
| 2 | PACLITAXEL | 10 |
| 3 | DEXAMETHASONE | 7 |
| 4 | DEXAMETHASONE 1.5 MG | 7 |
| 5 | GEMCITABINE HYDROCHLORIDE | 7 |
| 6 | LENALIDOMIDE | 7 |
| 7 | GEMCITABINE | 6 |
| 8 | BORTEZOMIB | 5 |
| 9 | BORTEXOMIB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUSPATERCEPT | 1 | 0.0014 |
| 1 | OLAPARIB | 11 | 0.0011 |
| 2 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0010 |
| 3 | ZINC OXIDE | 1 | 0.0007 |
| 4 | DEFERIPRONE | 1 | 0.0006 |
| 5 | SKIN PROTECTANT | 1 | 0.0005 |
| 6 | BORTEXOMIB | 4 | 0.0002 |
| 7 | BORTEZOMIB FOR INJECTION | 4 | 0.0002 |
| 8 | GEMCITABINE HYDROCHLORIDE | 7 | 0.0002 |
| 9 | HYDROXYUREA | 3 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 12 |
| 1 | Corticosteroid [EPC] | 11 |
| 2 | Platinum-based Drug [EPC] | 11 |
| 3 | Microtubule Inhibitor [EPC] | 10 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 7 |
| 5 | Thalidomide Analog [EPC] | 7 |
| 6 | Proteasome Inhibitor [EPC] | 5 |
| 7 | Antimetabolite [EPC] | 3 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 3 |
| 9 | Alkylating Drug [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 12 | 0.0005 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0001 |
| 2 | Microtubule Inhibitor [EPC] | 10 | 0.0001 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 11 | 0.0001 |
| 6 | Proteasome Inhibitor [EPC] | 5 | 0.0001 |
| 7 | Iron Chelator [EPC] | 1 | 0.0000 |
| 8 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 7 | 0.0000 |